With the revised law mandating the installation of CCTVs in operating rooms starting from September, hospitals are gearing up for the implementation. However, within the clinical field, there remains a lingering sense of confusion surrounding the precise details regarding the installation and operat
The Ministry of Food and Drug Safety (MFDS) is closely watching whether the recent reports about the possibility of glucagon-like peptide 1 (GLP-1) treatments causing suicidal or self-harming thoughts will also affect Korean patients.The ministry said it asked relevant companies to submit related da
A medical documentary set in a Korean university hospital, where the life, death, joy, and pain of human beings unfolded, attracted heated attention when it was released on Tving, an over-the-top (OTT) platform for Korean content, in late May. Viewers of "Human Chronicle" likened the show to a capti
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
Korea’s DTx market launched in earnest with the domestic approval of two cognitive-based treatment (CBT) digital therapeutics (DTx) for treating insomnia -- Aimmed’s Somzz and Welt’s Pillowbot in February and April, respectively.According to a report released on Tuesday by the Korea Innovative Medic
A Korean doctor expressed excitement that patients suffering from severe atopic dermatitis will be able to use Pfizer's Cibinqo with reduced financial burden thanks to the recent reimbursement.Cibinqo is a Janus kinase 1 (JAK1) inhibitor that was approved by the Ministry of Food and Drug Safety in N
A research team at Severance Hospital has developed artificial intelligence (AI) software that can predict the risk of chronic kidney disease (CKD) based on retinal examination results.A research team, led by Professors Joo Young-soo (left) at Yongin Severance Hospital and Park Jung-tak at Severance
CGBio, a Korean regenerative biopharmaceutical company, said Tuesday that Novomax Fusion, aitsnext-generation osteo-active bioglass ceramic cage, has received approval from Japan’s Pharmaceutical and Medical Devices Agency (PMDA).According to CGBio, Novomax Fusion is a synthetic glass-ceramic spacer
BeiGene Korea said on Tuesday that its Bruton's tyrosine kinase (BTK) inhibitor, Brukinsa 80 mg capsules (ingredient: zanubrutinib), recently obtained approval for the treatment of adult chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).This approval adds to Brukinsa’s previous
Korean researchers said they have discovered "for the first time globally" that endotrophin proteins, which increase when people gain weight, cause diabetes. Ulsan National Institute of Science and Technology (UNIST) said Tuesday that its research team, led by Professor Park Ji-young of the School o
The lobby of the main building of Inje University Seoul Paik Hospital was crowded with patients who came to get their medical records on Monday, the first day after the university announced the closing date of the hospital (Aug. 31). At the hospital entrance, there was the “Notice on closing Seoul P
The Ministry of Health and Welfare has expressed concern over the National Health and Medical Workers’ Union’s announcement of a general strike on Thursday.Minister of Health and Welfare Cho Kyoo-hong held the second emergency inspection meeting on Tuesday to review emergency treatment plans and the
One of the treatments for blood cancers, including leukemia, is a bone marrow transplant, a powerful immunotherapy that prevents relapse. The correct term for bone marrow transplant is "hematopoietic stem cell transplantation (HSCT).” In the past, a 100 percent histocompatibility antigen match betwe
Seegene's minority shareholders, angered by the continued fall of the company's stock price, are taking collective action, calling for the resignation of the founder and CEO Chun Jong-yoon.Seegene, the maker of Covid-19 PCR test devices, benefited greatly from the Covid-19 pandemic. While the compan
Lotte Biologics said on Tuesday that it signed a business agreement with a local biotech startup, Kanaph Therapeutics, to conduct joint research and development to build an antibody-drug conjugate (ADC) technology platform.Accordingly, both companies will conduct joint development over the next year
HK inno.N said on Monday that it launched its gastroesophageal reflux disease (GERD) drug K-CAB Tab. 50mg (ingredient: tegoprazan) in Indonesia which will be distributed under the product name, TEZA, in Indonesia via Kalbe Farma.HK inno.N's K-CAB is a new drug for GERD in the P-CAB class and has the
Korea is pretty late with the establishment of its first full-scale biobank but this also places them in the unique position to build their biobanks based on the experience of other fully established biobanks.The Human Genome Project launched in October 1990 was completed in April 2003, revealing th
Assets related to Hanmi Pharm's platform technology Orascovery, an oral drug discovery platform technology, will be transferred to C-Mer Eye Care Holdings, a Hong Kong-based healthcare company.Athenex, Hanmi's U.S. partner, which declared bankruptcy in May, recently signed an agreement to transfer i
The Ministry of Health and Welfare has recognized Korean students graduating from 159 overseas medical schools in 38 countries as eligible to take the Korean Medical Licensing Examination (KMLE), data by a lawmaker showed. Graduates of these foreign medical schools still need to take and pass a sepa
Theragen Bio and Korea University Ansan Hospital (KUAH) said they would team up to utilize precision genomic data.In a memorandum of understanding (MOU) signed between the two organizations last Thursday, Theragen Bio will leverage its over 10 years of expertise and technology to generate and provid